Blog

We are proud to announce Sproxil as a new Partner of the Fight the Fakes campaign! Every year, over 700,000 people die from fake tuberculosis and anti-malaria drugs alone. Fake medicines are a dangerous and deadly industry that particularly rampant in emerging markets—where limited resources and high prevalence of disease create many opportunities for illegal but profitable business. In the meantime, mobile phones are increasingly becoming the most popular mode of communication, especially across counties Read more…

Last week concluded the 2014 Global Forum on Access to Safe Medicines attended by Fight the Fakes partners International Council of Nurses (ICN), Institute of Research Against Counterfeit Medicines (IRACM), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the Medicines for Malaria Venture (MMV). The Global Forum allowed for stakeholders to discuss, present and explore ways to make medicines safer worldwide, tackling drug counterfeiting and supply chain security as well as international strategies and Read more…

The Center for Pharmaceutical Advancement and Training (CePAT) in Ghana has just received a Minilab to aid in detection fake medicines. Minilab checks medicines for the correct active pharmaceutical ingredients (API) and equips regulatory authorities with a portable and low-cost means of protecting patients from counterfeit drugs. Using Minilab, CePAT is able to test the quality of medicines in Ghana without necessarily returning to their lab. CePAT, established by the U.S. Pharmacopeial Convention (USP) in Read more…

The Council of Europe’s European Directorate for the Quality of Medicines (EDQM) has launched a database to collate incidents of drug counterfeiting across Europe. Titled, Know-X, the database aims to improve cross-border collaboration in the fight against fake medicines and shall also record the types of pharmaceutical products that are being counterfeited. To read more on the database and European-level developments to fight the fakes, click here.